XML 83 R37.htm IDEA: XBRL DOCUMENT v3.21.1
Nature of Business and Basis of Presentation - Additional Information (Detail) - USD ($)
$ / shares in Units, $ in Thousands
1 Months Ended 12 Months Ended
Jul. 20, 2020
Jul. 08, 2020
Jan. 31, 2021
Dec. 31, 2020
Jul. 07, 2020
Dec. 31, 2019
Nature of Business and Basis of Presentation [Line Items]            
Accumulated deficit       $ (404,228)   $ (189,482)
Number of shares issued in transaction 23,000,000          
Sale price of stock $ 20.00          
Issuance of common stock in public offering $ 425,293     425,293    
Underwriting discounts and commissions 32,200          
Expense on initial public offering $ 2,507     $ 2,507    
Conversion of stock shares converted 61,992,534          
Common stock shares authorized   150,000,000   150,000,000 260,000,000 260,000,000
Stockholders' Equity, Reverse Stock Split   one-for-3.55092        
Genentech [Member] | Subsequent Event [Member] | Collaboration and License Agreement [Member]            
Nature of Business and Basis of Presentation [Line Items]            
Upfront payment received     $ 75,000